Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 57, Issue 22, Pages 9644-9657Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm501399d
Keywords
-
Categories
Funding
- Lundbeck Foundation
- Danish Independent Research Council-Natural Sciences [10-080907]
- Carlsberg Foundation
Ask authors/readers for more resources
Natural, nonribosomal cyclotetrapeptides have traditionally been a rich source of inspiration for design of potent histone deacetylase (HDAC) inhibitors. We recently disclosed the total synthesis and full HDAC profiling of the naturally occurring azumamides ( J. Med. Chem. 2013, 56, 6512). In this work, we investigate the structural requirements for potent HDAC inhibition by macrocyclic peptides using the azumamides along with a series of unnatural analogues obtained through chemical synthesis. By solving solution NMR structures of selected macrocycles and combining these findings with molecular modeling, we pinpoint crucial enzymeligand interactions required for potent inhibition of HDAC(3). Docking of additional natural products confirmed these features to be generally important. Combined with the structural conservation across HDACs 13, this suggests that while cyclotetrapeptides have provided potent and class-selective HDAC inhibitors, it will be challenging to distinguish between the three major class I deacetylases using these chemotypes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available